Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J.D. Dhar is active.

Publication


Featured researches published by J.D. Dhar.


Bioorganic & Medicinal Chemistry | 1999

In search of new chemical entities with spermicidal and anti-HIV activities

Seema Srivastava; Lakshmi Kant Bajpai; Sanjay Batra; A. P. Bhaduri; Jagdamba P. Maikhuri; Gopal Gupta; J.D. Dhar

Several compounds belonging to 2-isoxazolines (4,5a-c), isoxazoles (3,6a-c) and 1-amino-1-cycloalkyl-2-substituted phenyl ethanes (16-18,a-e) have been synthesised and found to possess spermicidal activity. Out of these a couple of compounds (5a and 6a) exhibit anti-HIV activity.


Contraception | 2003

Mechanism of action of some acrylophenones, quinolines and dithiocarbamate as potent, non-detergent spermicidal agents

Jagdamba P. Maikhuri; Anil Kumar Dwivedi; J.D. Dhar; B.S. Setty; Gopal Gupta

Some suitably substituted acrylophenones, quinolines and dithiocarbamate were synthesized as new generation, non-detergent spermicides and were studied for their mechanism of action in comparison with various known spermicides belonging to several different classes of chemical compound. Nonoxynol-9, benzalkonium chloride, Sapindus saponins, verapamil, emetine and tartaric acid were used as reference molecules to study the effect of new spermicides on human sperm motility parameters (using computer-assisted semen analyzer), plasma membrane integrity, lipid peroxidation and defense system against reactive oxygen species (ROS). Results have indicated that sperm plasma membrane remains the primary site of action of most of the spermicides, though the effect may be predominantly on the physiological integrity rather than the structural integrity in case of the new compounds. Lipid peroxidation may play an important role in disrupting sperm membrane physiology that may or may not be accompanied with a detrimental effect on the defense system of the human spermatozoa against the ROS.


Contraception | 1989

Morphological changes in human spermatozoa as examined under scanning electron microscope after in vitro exposure to saponins isolated from sapindus mukorossi

J.D. Dhar; V.K. Bajpai; B.S. Setty; V.P. Kamboj

Saponins isolated from Sapindus mukorossi have potent spermicidal activity. Morphological changes in human ejaculated spermatozoa after exposure to these saponins were evaluated under Scanning Electron Microscope. The minimum effective concentration (0.05% in spot test) did not affect the surface topography after exposure for 1 minute. However, incubation of spermatozoa for 10 minutes resulted in extensive vesiculation and disruption of plasma membrane in the head region. Higher concentrations (0.1%, 1.25%, 2.5% and 5.0%) caused more or less similar changes which included vesiculation, vacuolation, disruption or erosion of membranes in the head region. These findings suggest that the morphological changes observed are due to alterations in the glycoproteins associated with the lipid bilayer of plasma membrane of spermatozoa.


Contraception | 1991

Biological profile of 2-[4-(2-n-piperidinoethoxy) phenyl]-3-phenyl (2h) benzo (b) pyran — A potent antiimplantation agent in rat

J.D. Dhar; B.S. Setty; S. Duran; R.S. Kapil

Compound CDRI-85/287: 2-[4-(2-N-piperidinoethoxy) phenyl]-3-phenyl (2H) benzo (b) pyran has been identified as a potent antiimplantation agent in rat. A single oral dose (2.5 mg/kg body weight) of the compound administered on days 1, 2 or 3 of pregnancy or multiple dosing (0.05 mg/kg daily) on days 5-7 postcoitum effectively prevented pregnancy. When administered on days 5-7 postcoitum, it failed to interrupt pregnancy even at 20 mg/kg dose. The compound is a potent antiestrogen, with very weak uterotrophic activity; it does not induce vaginal cornification in immature ovariectomised rat. Also, it is devoid of progestational, antiprogestational, androgenic, antiandrogenic and antigonadotrophic activities. The results suggest that the compound exerts its antiimplantation acivity in rat by virtue of its antiestrogenic activity [corrected].


Journal of Medical Primatology | 2000

Seasonal variations in daily sperm production rate of rhesus and bonnet monkeys

Gopal Gupta; Jagdamba P. Maikhuri; B.S. Setty; J.D. Dhar

Daily sperm production (DSP) rate was estimated in adult male rhesus and bonnet monkeys to evaluate seasonal changes in the gametogenic activity of the testes. Three monkeys of each species were castrated during breeding and non‐breeding seasons and DSP rate was estimated by enumerating the homogenization‐resistant spermatid nuclei of steps 13 and 14. Results indicated a significant reduction in the DSP rate per testis during the non‐breeding season in two species, along with a marked decline in the testis weight. However, the gametogenic capacity of seminiferous tubules did not appear to be markedly affected during non‐breeding season, as the DSP rate per gram parenchyma of testis was only marginally reduced. The seasonal changes in DSP were much more pronounced in the rhesus than in the bonnet monkey. The feasibility of circanual rhythm in DSP of sub‐human primates to form a baseline for the study of reproductive function in male is discussed.


Andrologia | 2009

Flutamide as an Androgen Antagonist on Epididymal Function in the Rat

J.D. Dhar; S.R. Srivastava; B.S. Setty

Die Wirkung von Flutamid als Androgenantagonist auf die Nebenhodenfunktion der Ratte


Contraception | 1994

Structure activity relationship of some 2,3-diaryl-2H-1-benzopyrans to their anti-implantation, estrogenic and antiestrogenic activities in rat

J.D. Dhar; Anil Kumar Dwivedi; Archana Srivastava; B.S. Setty

In an endeavour to develop potent anti-implantation agents, a new antiestrogen, CDRI 85/287 (2-(4-2-piperidinoethoxy)phenyl-3-phenyl(2H)benzo(b)pyran), virtually devoid of agonistic activity, was identified. The present study deals with anti-implantation and estrogen agonistic-antagonistic activities of four structural analogues of 85/287. Results show that none of the compounds induced vaginal cornification, even at doses as high as 2.5 mg/kg. Compounds having p-hydroxyphenyl group at position-3 or hydroxy group at position-7 showed better estrogen receptor affinity (6.6 and 25.3% E2) as well as antiestogenic activity. When 3-p-hydroxyphenyl was replaced by 3-p-methoxyphenyl, a marked reduction in the receptor affinity was observed. However, this compound was relatively more potent as an anti-implantation agent, possibly due to its conversion to hydroxylated metabolite in vivo. The provision of aminoethoxy side chain at para-position and a shift in the piperidinoethoxy side chain from position-4 to position-2 in these molecules resulted in a decrease in estrogenicity and increase in antagonistic property. Results are discussed with regard to molecular configuration, relative binding affinity of these compounds to their biological profile.


European Journal of Medicinal Chemistry | 2002

Substituted acrylophenones and related mannich bases as possible spermicides and inhibitors of HIV envelope glycoprotein-CD4 interaction.

Niharika Kumaria; Anil Kumar Dwivedi; Jagdamba P. Maikhuri; Gopal Gupta; Saman Habib; J.D. Dhar; Satyawan Singh

Several appropriately substituted 4-(dialkylamino-alkyl)-substituted-styryl-alkyl ketones or acetophenones were prepared and subjected to the Mannich reaction to yield compounds that would incorporate both alpha,beta-unsaturated keto groups and a substituted aminomethyl function with or without another olefinic moiety at position 4. The spermicidal activity of the prepared compounds was evaluated. Several compounds 2d, 4a and 4e were found to possess spermicidal activity at 0.005% concentration, while compounds 2a, 2c, 2f, 3a and 4b were active at 0.01% concentration. Compounds 2a, 2c, 3a, 4a and 4e also inhibited the interaction between recombinant HIV Env and CD4. Out of these, compound 2c was found to be most active.


Journal of Medical Primatology | 2003

Seasonal changes in the seminiferous epithelium of rhesus and bonnet monkeys.

F.W. Bansode; S.R. Chowdhury; J.D. Dhar

Abstract: With a view to elucidate seasonal variations in testicular spermatogenesis, quantitative analysis of spermatogenic cells was carried out in non‐human primate species viz. rhesus (Macaca mulatta) and bonnet (M. radiata) monkeys during breeding (October–December) and non‐breeding (May–June) seasons. The results revealed significant inhibition of testicular germ cell population during non‐breeding compared with the breeding period in both the species. Quantitative determination of Sertoli cell–germ cell ratio showed a marked decrease in the number of type A‐spermatogonia, spermatocytes (non‐pachytene and pachytene) and spermatids (in steps 1–12 of spermiogenesis) in rhesus monkey during the non‐breeding period. Bonnet monkeys exhibited the significant decline in the number of primary spermatocytes and spermatids during the non‐breeding phase. In addition, average diameter of round seminiferous tubules and nuclear diameter of Leydig cells also decreased significantly in rhesus monkeys. However, bonnet monkeys did not show any significant change in nuclear diameter/morphology of Leydig cells, testicular tubular diameter and number of type A‐spermatogoniae. Sertoli cell number did not show any significant change during both breeding and non‐breeding periods in both the species. The results of this study indicate a prominent seasonal variation in testicular spermatogenic/Leydig cells in rhesus monkeys than those observed in bonnet monkeys.


Endocrine Research | 1998

Estrogen, androgen and antiestrogen responses in the accessory organs of male rats during different phases of life

J.D. Dhar; R Mishra; B.S. Setty

Recent studies have indicated that estrogen has a stimulatory influence on the male reproductive tract. Evidence includes the presence of measurable levels of estrogen in the circulation, retention of exogenous estrogen, and presence of estrogen receptors in the male accessory sex organs during prepubertal life. In the present study, estrogen antagonists (CDRI-85/287 and centchroman) have been used to examine this concept by antagonising estrogen action at critical stages in the life in rat. Centchroman or 85/287 administration to 14 day old rats for 7 days did not alter gonadal or accessory organ weight. In contrast, in 21 day old castrated rats, treatment with either compound from day 28-35 of life stimulated an increase in all organ weights. When administered to normal rats during the critical phase of transition, i.e. days 30-60 of life, both testis and accessory organs showed an increase in weight. In contrast castrated rats treated with estrogen alone or in combination with 85/287 from days 37-45 of life and sacrificed on day 46 did not show any change, but 85/287 per se markedly reduced the weight of accessory organs. In adult castrated rats, the potency of DHT as a promoter of growth was potentiated by estradiol. Compound 85/287 negated the estradiol-induced increase. Glycerylphosphorylcholine (GPC) and sialic acid levels showed about 100% increase, with both high and low doses of 85/287 (treated from 30-60 days of life), However, centchroman (CDRI-67/20) was less potent in this regard. The effect of estrogen antagonists in relation to epididymal physiology during different phases of life in the rat is discussed.

Collaboration


Dive into the J.D. Dhar's collaboration.

Top Co-Authors

Avatar

B.S. Setty

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Anil Kumar Dwivedi

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Gopal Gupta

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Jagdamba P. Maikhuri

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

B. Sreenivasulu Setty

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

F.W. Bansode

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Niharika Kumaria

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Priti Ojha

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Satyawan Singh

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

V.K. Bajpai

Central Drug Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge